Tranzyme Pharma to Present at the 27th Annual JP Morgan Healthcare Conference

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Tranzyme Pharma, a clinical stage biopharmaceutical company engaged in the discovery and development of first-in-class small molecule therapeutics, announced today that Vipin K. Garg, Ph.D., President and CEO, will present at the upcoming 27th Annual JP Morgan Healthcare Conference being held from January 12-15, 2009. Tranzyme’s presentation will take place on Monday, January 12, 2009 at 8:30 a.m. PST at the Westin St. Francis Hotel in San Francisco, CA.

MORE ON THIS TOPIC